TY - STD TI - American Cancer Society. Cancer facts and figures 2018. 2020. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf. UR - https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf ID - ref1 ER - TY - JOUR AU - Avazzadeh, R. AU - Vasheghani-farahani, E. AU - Soleimani, M. AU - Amanpour, S. AU - Sadeghi, M. PY - 2017 DA - 2017// TI - Synthesis and application of magnetite dextran-spermine nanoparticles in breast cancer hyperthermia JO - Prog Biomater VL - 6 UR - https://doi.org/10.1007/s40204-017-0068-8 DO - 10.1007/s40204-017-0068-8 ID - Avazzadeh2017 ER - TY - STD TI - BREASTCANCER.ORG (2020) U.S. breast cancer statistics. https://www.breastcancer.org/symptoms/understand_bc/statistics. UR - https://www.breastcancer.org/symptoms/understand_bc/statistics ID - ref3 ER - TY - JOUR AU - Cao, X. AU - Yu, H. AU - Chen, C. AU - Wei, J. AU - Wang, P. PY - 2015 DA - 2015// TI - Expression and characterization of recombinant humanized anti-HER2 single-chain antibody in Pichia pastoris for targeted cancer therapy JO - Biotechnol Lett VL - 37 UR - https://doi.org/10.1007/s10529-015-1804-6 DO - 10.1007/s10529-015-1804-6 ID - Cao2015 ER - TY - STD TI - Chan C, Cai Z. 2020. https://link.springer.com/article/10.1007/s11095-013-1044-1. UR - https://link.springer.com/article/10.1007/s11095-013-1044-1 ID - ref5 ER - TY - STD TI - Chemocare.com. Ado-Trastuzumab Emtansin. 2019. https://chemocare.com/chemotherapy/drug-info/ado-trastuzumab-emtansine.aspx. UR - http://chemocare.com/chemotherapy/drug-info/ado-trastuzumab-emtansine.aspx ID - ref6 ER - TY - JOUR AU - Chiang, C. -. S. AU - Hu, S. -. H. AU - Liao, B. -. J. AU - Chang, Y. -. C. AU - Chen, S. -. Y. PY - 2014 DA - 2014// TI - Enhancement of cancer therapy efficacy by trastuzumab-conjugated and pH-sensitive nanocapsules with the simultaneous encapsulation of hydrophilic and hydrophobic compounds JO - Nanomed Nanotechnol Biol Med VL - 10 UR - https://doi.org/10.1016/j.nano.2013.07.009 DO - 10.1016/j.nano.2013.07.009 ID - Chiang2014 ER - TY - JOUR AU - Cho, E. C. AU - Liu, Y. AU - Xia, Y. PY - 2010 DA - 2010// TI - A simple spectroscopic method for differentiating cellular uptakes of gold nanospheres and nanorods from their mixtures JO - Angew Chem Int Ed VL - 49 UR - https://doi.org/10.1002/anie.200906584 DO - 10.1002/anie.200906584 ID - Cho2010 ER - TY - JOUR AU - Choi, W. I. AU - Lee, J. H. AU - Kim, J. -. Y. AU - Heo, S. U. AU - Jeong, Y. Y. AU - Kim, Y. H. AU - Tae, G. PY - 2015 DA - 2015// TI - Targeted antitumor efficacy and imaging via multifunctional nano-carrier conjugated with anti-HER2 trastuzumab JO - Nanomed Nanotechnol Biol Med VL - 11 UR - https://doi.org/10.1016/j.nano.2014.09.009 DO - 10.1016/j.nano.2014.09.009 ID - Choi2015 ER - TY - JOUR AU - Cruz, E. AU - Kayser, V. PY - 2019 DA - 2019// TI - Synthesis and enhanced cellular uptake in vitro of anti-HER2 multifunctional gold nanoparticles JO - Cancers UR - https://doi.org/10.3390/cancers11060870 DO - 10.3390/cancers11060870 ID - Cruz2019 ER - TY - JOUR AU - Dawidczyk, C. M. AU - Russell, L. M. AU - Searson, P. C. PY - 2014 DA - 2014// TI - Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments JO - Front Chem UR - https://doi.org/10.3389/fchem.2014.00069 DO - 10.3389/fchem.2014.00069 ID - Dawidczyk2014 ER - TY - JOUR AU - Day, E. S. AU - Bickford, L. R. AU - Slater, J. H. AU - Riggall, N. S. AU - Drezek, R. A. AU - West, J. L. PY - 2010 DA - 2010// TI - Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer JO - Int J Nanomed VL - 5 UR - https://doi.org/10.2147/IJN.S10881 DO - 10.2147/IJN.S10881 ID - Day2010 ER - TY - JOUR AU - Ding, H. AU - Gangalum, P. R. AU - Galstyan, A. AU - Fox, I. AU - Patil, R. AU - Hubbard, P. PY - 2017 DA - 2017// TI - HER2-positive breast cancer targeting and treatment by a peptide-conjugated mini nanodrug JO - Nanomed Nanotechnol Biol Med VL - 13 UR - https://doi.org/10.1016/j.nano.2016.07.013 DO - 10.1016/j.nano.2016.07.013 ID - Ding2017 ER - TY - STD TI - Dreaden EC. The golden age: gold nanoparticles for biomedicine. Chem Soc Rev. 2012;(7):2521–3012. ID - ref14 ER - TY - JOUR AU - Emami, M. AU - Shamsipur, M. AU - Saber, R. AU - Irajirad, R. PY - 2014 DA - 2014// TI - An electrochemical immunosensor for detection of a breast cancer biomarker based on antiHER2—iron oxide nanoparticle bioconjugates JO - Analyst VL - 139 UR - https://doi.org/10.1039/C4AN00183D DO - 10.1039/C4AN00183D ID - Emami2014 ER - TY - STD TI - Fam-Trastuzumab Deruxtecan. Drugs.com. 2020. https://www.drugs.com/ppa/fam-trastuzumab-deruxtecan.html. UR - https://www.drugs.com/ppa/fam-trastuzumab-deruxtecan.html ID - ref16 ER - TY - JOUR AU - Gener, P. AU - Gouveia, L. P. AU - Sabat, G. R. AU - Sousa Rafael, D. F. AU - Fort, N. B. AU - Arranja, A. PY - 2015 DA - 2015// TI - Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells JO - Nanomed Nanotechnol Biol Med VL - 11 UR - https://doi.org/10.1016/j.nano.2015.07.009 DO - 10.1016/j.nano.2015.07.009 ID - Gener2015 ER - TY - STD TI - Ghosh P, Han G, De M, Kim CK, Rotello VM. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 2008;1307–15. ID - ref18 ER - TY - JOUR AU - Hicks, D. G. PY - 2008 DA - 2008// TI - Her2+ breast cancer: review of biologic relevance and optimal use of diagnostic tools JO - Am J Clin Pathol VL - 129 UR - https://doi.org/10.1309/99AE032R9FM8WND1 DO - 10.1309/99AE032R9FM8WND1 ID - Hicks2008 ER - TY - JOUR AU - Jiang, Q. AU - Hao, S. AU - Xiao, X. AU - Yao, J. AU - Ou, B. AU - Zhao, Z. PY - 2016 DA - 2016// TI - Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers JO - Breast Cancer VL - 23 UR - https://doi.org/10.1007/s12282-014-0581-8 DO - 10.1007/s12282-014-0581-8 ID - Jiang2016 ER - TY - JOUR AU - Kang, X. AU - Guo, X. AU - An, W. AU - Niu, X. AU - Li, S. AU - Liu, Z. PY - 2017 DA - 2017// TI - Photothermal therapeutic application of gold nanorods-porphyrin-trastuzumab complexes in HER2-positive breast cancer JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/srep42069 DO - 10.1038/srep42069 ID - Kang2017 ER - TY - JOUR AU - Kulhari, H. AU - Pooja, D. AU - Shrivastava, S. AU - Kuncha, M. AU - Naidu, V. G. M. AU - Bansal, V. PY - 2016 DA - 2016// TI - Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep23179 DO - 10.1038/srep23179 ID - Kulhari2016 ER - TY - JOUR AU - Lee, H. AU - Dam, D. H. M. AU - Ha, J. W. AU - Yue, J. AU - Odom, T. W. PY - 2015 DA - 2015// TI - Enhanced human epidermal growth factor receptor 2 degradation in breast cancer cells by lysosome-targeting gold nanoconstructs JO - ACS Nano VL - 9 UR - https://doi.org/10.1021/acsnano.5b05138 DO - 10.1021/acsnano.5b05138 ID - Lee2015 ER - TY - JOUR AU - Lu, J. AU - Liu, X. AU - Liao, Y. -. P. AU - Wang, X. AU - Ahmed, A. AU - Jiang, W. PY - 2018 DA - 2018// TI - Breast cancer chemo-immunotherapy through liposomal delivery of an immunogenic cell death stimulus plus interference in the IDO-1 pathway JO - ACS Nano VL - 12 UR - https://doi.org/10.1021/acsnano.8b05189 DO - 10.1021/acsnano.8b05189 ID - Lu2018 ER - TY - STD TI - Martínez-Jothar LM-J. Selective cytotoxicity to HER2 positive breast cancer cells by saporin-loaded nanobody-targeted polymeric nanoparticles in combination with photochemical internalization. Mol Pharm. 2020;1633–47. ID - ref25 ER - TY - STD TI - Miyano T. ACS Publications. 2020. https://pubs.acs.org/doi/abs/10.1021/mp100105c. UR - https://pubs.acs.org/doi/abs/10.1021/mp100105c ID - ref26 ER - TY - JOUR AU - Mu, Q. AU - Kievit, F. M. AU - Kant, R. J. AU - Lin, G. AU - Jeon, M. AU - Zhang, M. PY - 2015 DA - 2015// TI - Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells JO - Nanoscale VL - 7 UR - https://doi.org/10.1039/C5NR04867B DO - 10.1039/C5NR04867B ID - Mu2015 ER - TY - JOUR AU - Navas-Moreno, M. AU - Mehrpouyan, M. AU - Chernenko, T. AU - Candas, D. AU - Fan, M. AU - Li, J. J. PY - 2017 DA - 2017// TI - Nanoparticles for live cell microscopy: a surface-enhanced Raman scattering perspective JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-04066-0 DO - 10.1038/s41598-017-04066-0 ID - Navas-Moreno2017 ER - TY - JOUR AU - NDong, C. AU - Tate, J. A. AU - Kett, W. C. AU - Batra, J. AU - Demidenko, E. AU - Lewis, L. D. PY - 2015 DA - 2015// TI - Tumor cell targeting by iron oxide nanoparticles is dominated by different factors in vitro versus in vivo JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0115636 DO - 10.1371/journal.pone.0115636 ID - NDong2015 ER - TY - JOUR AU - Panariti, A. AU - Miserocchi, G. AU - Rivolta, I. PY - 2012 DA - 2012// TI - The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? JO - Nanotechnol Sci Appl VL - 5 UR - https://doi.org/10.2147/NSA.S25515 DO - 10.2147/NSA.S25515 ID - Panariti2012 ER - TY - JOUR AU - Patiño, T. AU - Soriano, J. AU - Barrios, L. AU - Ibáñez, E. AU - Nogués, C. PY - 2015 DA - 2015// TI - Surface modification of microparticles causes differential uptake responses in normal and tumoral human breast epithelial cells JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep11371 DO - 10.1038/srep11371 ID - Patiño2015 ER - TY - STD TI - PERJETA and HER2+ breast cancer. 2019. https://www.perjeta.com/hcp/breast-cancer/about-perjeta.html?c=per-1645c217be4&gclid=EAIaIQobChMIlNHu2oG_5QIVCtbACh3SMghiEAAYAiAAEgJNWvD_BwE&gclsrc=aw.ds. UR - https://www.perjeta.com/hcp/breast-cancer/about-perjeta.html?c=per-1645c217be4&gclid=EAIaIQobChMIlNHu2oG_5QIVCtbACh3SMghiEAAYAiAAEgJNWvD_BwE&gclsrc=aw.ds ID - ref32 ER - TY - STD TI - Priyambada Parhi SK. Trastuzumab guided nanotheranostics: a lipid based multifunctional nanoformulation for targeted drug delivery and imaging in breast cancer therapy. J Colloid Interface Sci. 2015;198–211. ID - ref33 ER - TY - JOUR AU - Qiao, S. AU - Zhao, Y. AU - Geng, S. AU - Li, Y. AU - Hou, X. AU - Liu, Y. PY - 2016 DA - 2016// TI - A novel double-targeted nondrug delivery system for targeting cancer stem cells JO - Int J Nanomed VL - 11 UR - https://doi.org/10.2147/IJN.S116230 DO - 10.2147/IJN.S116230 ID - Qiao2016 ER - TY - STD TI - Rameshwer Shukla TP-L. 2020. https://pubs.acs.org/doi/abs/10.1021/bc050348p UR - https://pubs.acs.org/doi/abs/10.1021/bc050348p ID - ref35 ER - TY - JOUR AU - Rao, W. AU - Wang, H. AU - Han, J. AU - Zhao, S. AU - Dumbleton, J. AU - Agarwal, P. PY - 2015 DA - 2015// TI - Chitosan-decorated doxorubicin-encapsulated nanoparticle targets and eliminates tumor reinitiating cancer stem-like cells JO - ACS Nano VL - 9 UR - https://doi.org/10.1021/nn506928p DO - 10.1021/nn506928p ID - Rao2015 ER - TY - JOUR AU - Rizvi, S. B. AU - Rouhi, S. AU - Taniguchi, S. AU - Yang, S. Y. AU - Green, M. AU - Keshtgar, M. AU - Seifalian, A. M. PY - 2014 DA - 2014// TI - Near-infrared quantum dots for HER2 localization and imaging of cancer cells JO - Int J Nanomed VL - 9 UR - https://doi.org/10.2147/IJN.S51535 DO - 10.2147/IJN.S51535 ID - Rizvi2014 ER - TY - STD TI - Shakil MS, Hasan MA, Sarker SR. Iron oxide nanoparticles for breast cancer theranostics. Curr Drug Metab. 2019;446–56. ID - ref38 ER - TY - STD TI - Sperling PRRA, et al. Biological applications of gold nanoparticles. Chem Soc Rev. 2008;(9):1745–2140. ID - ref39 ER - TY - STD TI - Sutapa Barua J-WY. Particle shape enhances specificity of antibody-displaying nanoparticles. 2020 ID - ref40 ER - TY - STD TI - Targeted Therapy. National Breast Cancer Foundation, Inc. 2019. https://www.nationalbreastcancer.org/breast-cancer-targeted-therapy. UR - https://www.nationalbreastcancer.org/breast-cancer-targeted-therapy ID - ref41 ER - TY - STD TI - Targeted Therapy for Breast Cancer. American Cancer Society. 2019. https://www.cancer.org/cancer/breast-cancer/treatment/targeted-therapy-for-breast-cancer.html. UR - https://www.cancer.org/cancer/breast-cancer/treatment/targeted-therapy-for-breast-cancer.html ID - ref42 ER - TY - JOUR AU - Truffi, M. AU - Colombo, M. AU - Sorrentino, L. AU - Pandolfi, L. AU - Mazzucchelli, S. PY - 2018 DA - 2018// TI - Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells JO - Sci Rep VL - 8 UR - https://doi.org/10.1038/s41598-018-24968-x DO - 10.1038/s41598-018-24968-x ID - Truffi2018 ER - TY - STD TI - Tucatinib. PubChem. 2020. https://pubchem.ncbi.nlm.nih.gov/compound/Tucatinib. UR - https://pubchem.ncbi.nlm.nih.gov/compound/Tucatinib ID - ref44 ER - TY - STD TI - U.S. National Library of Medicine. Neratinib. 2019. https://pubchem.ncbi.nlm.nih.gov/compound/Neratinib. UR - https://pubchem.ncbi.nlm.nih.gov/compound/Neratinib ID - ref45 ER - TY - JOUR AU - Wang, Z. AU - Wang, W. AU - Bu, X. AU - Wei, Z. AU - Geng, L. AU - Wu, Y. PY - 2015 DA - 2015// TI - Microarray based screening of peptide nano probes for HER2 positive tumor JO - Anal Chem VL - 87 UR - https://doi.org/10.1021/acs.analchem.5b01588 DO - 10.1021/acs.analchem.5b01588 ID - Wang2015 ER - TY - JOUR AU - Zhang, Y. AU - Yang, C. AU - Wang, W. AU - Liu, J. AU - Liu, Q. AU - Huang, F. PY - 2016 DA - 2016// TI - Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer JO - Sci Rep UR - https://doi.org/10.1038/srep21225 DO - 10.1038/srep21225 ID - Zhang2016 ER -